The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...
Prof. Chris Goetz, co-creator of the MDS-UPDRS, is a leading expert in movement disorder pharmacology and rating-scale development. He is a professor in the Department of Neurological Sciences and ...
GOTHENBURG, SE, SE / ACCESS Newswire / October 2, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, October 2, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company ...
While about 11 percent of children (4-17 years old) nationwide have been diagnosed with attention-deficit hyperactivity disorder (ADHD), the long-term health effects of having ADHD and of common ADHD ...
Stress can have a negative effect on anyone's health but presents particular challenges for people with Parkinson's disease. Kim Seroogy, PhD, said previous research from his team has shown that ...
Bronwyn Bridges, CEO of PragmaClin Research Inc., began her academic journey in biology before transitioning to pharmacology. Driven by a deep interest in brain health, Bridges focused on Parkinson's ...
The unparalleled collective clinical expertise of the board will strengthen NeuraLight's validation-first strategy, which has already produced movement-based progression measures with 10x more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results